Clinical study of non-invasive high frequency oscillatory ventilation combined with pulmonary surfactant in treatment of neonates with neonatal respiratory distress syndrome
-
摘要: 目的 探讨无创高频震荡通气(NHFOV)联合肺表面活性物质(PS)治疗新生儿呼吸窘迫综合征的临床效果。 方法 选取60例新生儿呼吸窘迫综合征患儿,随机分为对照组与观察组各30例。对照组采用无创间歇正压通气(NIPPV)联合PS治疗,观察组采用NHFOV联合PS治疗。比较2组患儿的治疗效果、平均动脉压(MAP)、动脉血氧分压[p(O2)]、动脉血二氧化碳分压[p(CO2)]、吸入气中的氧浓度分数(FiO2)、氧合指数(OI)及并发症发生情况。 结果 观察组总有效率为90.0%, 显著高于对照组的70.0%(P<0.05)。治疗后,观察组的p(O2)水平高于对照组, MAP、p(CO2)、FiO2、OI水平低于对照组,差异均有统计学意义(P<0.05)。2组患儿肺炎、气胸、肺出血等并发症发生率比较无显著差异(P>0.05)。 结论 NHFOV联合PS治疗新生儿呼吸窘迫综合征效果显著,可明显改善动脉血气指标,且不会增加并发症发生率。
-
关键词:
- 无创高频震荡通气 /
- 肺表面活性物质 /
- 新生儿呼吸窘迫综合征 /
- 并发症 /
- 氧合指数
Abstract: Objective To explore the effect of non-invasive high frequency oscillatory ventilation(NHFOV)combined with pulmonary surfactant(PS)in the treatment of neonates with neonatal respiratory distress syndrome. Methods A total of 60 neonates with neonatal respiratory distress syndrome were selected and randomly divided into control group(n=30)and observation group(n=30). The control group was treated with non-invasive positive pressure ventilation(NIPPV)and PS, while the observation group was treated with NHFOV and PS. The therapeutic effect, mean arterial pressure(MAP), arterial oxygen partial pressure [p(O2)], arterial carbon dioxide partial pressure [p(CO2)], fraction of inspiration O2(FiO2), oxygenation index(OI)and complications were compared between the two groups. Results The total effective rate of the observation group was 90.0%, which was significantly higher than 70.0% of the control group(P<0.05). After treatment, the p(O2)level of the observation group was significantly higher than that of the control group, and the MAP, p(CO2), FiO2 and OI levels of the observation group were significantly lower than the control group(P<0.05). There were no significant differences in the incidence rates of pneumonia, pneumothorax and pulmonary hemorrhage between the two groups(P>0.05). Conclusion NHFOV combined with PS shows a significant effect in the treatment of neonates with neonatal respiratory distress syndrome, which can significantly improve the arterial blood gas indexes without increasing the incidence of complications. -
-
刘孝桥, 涂睿. 盐酸氨溴索联合牛肺表面活性物质治疗早产儿呼吸窘迫综合征的临床疗效观察[J]. 实用临床医药杂志, 2017, 21(15): 49-52. 唐烁, 包蕾. 新生儿急性呼吸窘迫综合征临床特征与预后相关因素分析[J]. 第三军医大学学报, 2019, 41(9): 898-902. Howard M E, Piper A J, Stevens B, et al. A randomized controlled trial of CPAP versus non-invasive ventilation for initial treatment of obesity hypoventilation syndrome[J]. Thorax, 2017, 72(5): 437-442.
迟明, 梅亚波, 封志纯. 新生儿急性呼吸窘迫综合征研究进展[J]. 中国当代儿科杂志, 2018, 20(9): 724-728. 石永言, 富建华. 《2019年欧洲呼吸窘迫综合征管理指南》解读[J]. 中国实用儿科杂志, 2019, 34(6): 461-465. 吴永文. 甲泼尼龙琥珀酸钠对呼吸窘迫综合征患者肺功能及炎症状况的影响[J]. 实用临床医药杂志, 2019, 23(9): 61-64. 李科纯, 钱素云, 曾健生. 肺表面活性物质治疗急性呼吸窘迫综合征研究现状[J]. 中国实用儿科杂志, 2018, 33(6): 431-434. 常明, 卢红艳, 相虹, 等. 不同机械通气方式联合肺表面活性物质对新生儿急性肺损伤/急性呼吸窘迫综合征疗效比较[J]. 中国当代儿科杂志, 2016, 18(11): 1069-1074. 中国医师协会新生儿科医师分会, 中华儿科杂志编辑委员会. 早产儿经鼻间歇正压通气临床应用指南[J]. 中华儿科杂志, 2019, 57(4): 248-251. 中华医学会儿科学分会新生儿学组. 早产儿无创支持临床应用建议[J]. 中华儿科杂志, 2018, 56(9): 643-647. 王明强, 祁绍艳. 高频震荡通气对急性呼吸窘迫综合征患者氧代谢和炎症因子的影响[J]. 南京医科大学学报: 自然科学版, 2016, 36(4): 444-448. Mukerji A, Shah V. Response to ‘Non-invasive high frequency ventilation and the errors from the past: designing simple trials neglecting complex respiratory physiology’[J]. J Perinatol, 2017, 37(9): 1067-1073.
娄五斌, 张卫星, 员丽, 等. 无创高频振荡通气和双水平正压通气在早产儿呼吸窘迫综合征中的临床应用效果比较研究[J]. 中国全科医学, 2018, 21(16): 1983-1988. 黄静, 林新祝, 郑直. 高频振荡通气联合肺表面活性物质治疗新生儿重型胎粪吸入综合征并发肺出血的临床研究[J]. 中国当代儿科杂志, 2016, 18(11): 1075-1079. -
期刊类型引用(3)
1. 刘锐,刘付昌盛,卢梦月,田智. 慢性阻塞性肺疾病急性加重痰热壅肺证尿液代谢组学研究. 河北中医. 2023(04): 583-588 . 百度学术
2. 罗燕青,张作清,张昌红. 慢性阻塞性肺疾病患者血清及肺泡灌洗液中CTGF、TGF-β1的水平及意义研究. 国际检验医学杂志. 2018(08): 913-916+921 . 百度学术
3. 许红,刘力,韩彦洁,张瑶. 不明原因复发性流产患者干血斑中多种氨基酸水平分析. 现代医学. 2018(01): 4-6 . 百度学术
其他类型引用(1)
计量
- 文章访问数: 348
- HTML全文浏览量: 79
- PDF下载量: 8
- 被引次数: 4